2026-04-13T15:07:53Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/127142025-10-24T10:27:18Zcom_2072_378070com_2072_378040col_2072_378092

00925njm 22002777a 4500 dc DeFilipp, Zachariah author Holderried, Tobias author Mehra, Varun author Michonneau, David author Pashley, Alex author Fox, Maria Laura author 2025-03-07T11:43:26Z 2025-03-07T11:43:26Z 2024 2025-02 Chronic graft-versus-host disease; Extracorporeal photopheresis; Steroid-refractory disease Enfermedad crónica de injerto contra huésped; Fotoféresis extracorpórea; Enfermedad refractaria a esteroides Malaltia crònica d'empelt contra hoste; Fotofèresi extracorpòria; Malaltia refractaria als esteroides The objective of this meta-analysis (MA) was to evaluate the efficacy and safety of extracorporeal photopheresis (ECP) for the treatment of steroid-refractory chronic graft-versus-host disease (SR-cGvHD). A systematic literature review (SLR) was conducted according to PRISMA guidelines, followed by a feasibility assessment (FA) to assess potential between-study heterogeneity in the meta-analysis (MA). Random-effects MAs were performed for overall survival (OS), failure-free survival (FFS), overall response rate (ORR) and skin-specific response. A subgroup analysis was conducted to explore the effect of NIH assessment criteria. The SLR identified 627 records; 45 unique studies were ultimately included in the MA. For patients treated with ECP, at Month 12, the pooled OS rate was 83.97% and the pooled FFS rate was 60.79%. ORR was 45.34% at Months 3 to 4 and 58.23% at Months 6 to 8. Subgroup analyses showed no significant difference in ORR between studies utilizing NIH criteria and those utilizing non-NIH criteria. Skin-specific response was 34.86% at Months 2 to 3 and 54.22% at Months 4 to 6. There was considerable heterogeneity across all analyses, with I2 values ranging from 65% to 91%. This SLR and MA indicates that ECP results in favorable outcomes in the treatment of SR-cGvHD, including OS, FFS and ORR. This study was funded by Mallinckrodt Pharmaceuticals. http://hdl.handle.net/11351/12714 Avaluació de resultats (Assistència sanitària) Malalties cròniques Esteroides - Ús terapèutic Empelt contra l'hoste, Malaltia de l' - Fototeràpia ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome DISEASES::Immune System Diseases::Graft vs Host Disease Other subheadings::Other subheadings::/therapy CHEMICALS AND DRUGS::Polycyclic Compounds::Fused-Ring Compounds::Steroids Other subheadings::Other subheadings::/therapeutic use DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Chronic Disease ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Phototherapy::Ultraviolet Therapy::PUVA Therapy::Photopheresis TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento ENFERMEDADES::enfermedades del sistema inmune::enfermedad injerto contra huésped Otros calificadores::Otros calificadores::/terapia COMPUESTOS QUÍMICOS Y DROGAS::compuestos policíclicos::compuestos con anillos de fusión::esteroides Otros calificadores::Otros calificadores::/uso terapéutico ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedad crónica TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::fototerapia::tratamiento con rayos ultravioleta::tratamiento PUVA::fotoféresis Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease